Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington's disease.

Saved in:

Bibliographic Details
Title:	Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington's disease.
Authors:	Bhatnagar A; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States., Parmar V; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States.; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States., Barbieri N; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States.; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States., Bearoff F; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States., Elefant F; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States., Kortagere S; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
Source:	Frontiers in behavioral neuroscience [Front Behav Neurosci] 2023 Jun 07; Vol. 17, pp. 1176777. Date of Electronic Publication: 2023 Jun 07 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477952 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5153 (Print) Linking ISSN: 16625153 NLM ISO Abbreviation: Front Behav Neurosci Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1662-5153
DOI:	10.3389/fnbeh.2023.1176777